For citations:
Kushlinskii N.E., Kovaleva O.V., Kuzmin Yu.B., Samoilova E.V., Prishchep P.L., Gershtein E.S., Varfolomeeva S.R., Rogozhin D.V., Sokolov N.Yu., Borzov K.A., Sushentsov E.A., Valiev A.K., Stilidy I.S. The content of sEMMPRIN/CD147 in the blood serum of patients with bone tumors and its relationship with the clinical and morphological characteristics of the disease. Advances in Molecular Oncology. 2023;10(2):100-107. (In Russ.) https://doi.org/10.17650/2313-805X-2023-10-2-100-107
Email this article 